• Skip to Content

.

 Indiana University Indiana University IU

Search

IU Simon Comprehensive Cancer Center Indiana University Melvin and Bren Simon Comprehensive Cancer CenterA National Cancer Institute Comprehensive Cancer Center

  • About Us
    • Our Mission & Goals
    • Our Leadership
    • Our Members (Scientists, Physician-scientists)
    • Our Partners
    • Travel
  • Research & Clinical Trials
    • Clinical Trials
    • Research Programs
    • DHART SPORE
    • Member Directory
    • Become a Member
    • Shared Facilities
    • Research Resources
    • Funding Opportunities
    • Refer a Patient
  • Career Enhancement & Related Activities
    • Aims
    • Training Programs
    • Trainee Membership
    • Fellowships
    • Presentations
    • Cancer Research Day
    • Amelia Project
    • Andrea Gianaris Pancreatic Cancer Symposium
    • William J. Wright Scholarship Fund
  • News & Publications
    • News
    • News Archives
    • Publications
  • Office of Community Outreach & Engagement
  • Giving
Staff Login
  • Patient Care at IU Health
  • IU School of Medicine
  • Research & Clinical Trials
  • Clinical Trials
  • Find a Trial
  • Trial Results

Research & Clinical Trials

Find a Trial

Trial Results


5 protocol(s) meet the specified criteria
PHO-IIR-IUSCC-0755OPEN TO ACCRUAL
ANTHROPOMETRIC AND BIOCHEMICAL MARKERS OF NUTRITION IN CHILDREN WITH CANCER: A PILOT INVESTIGATION OF GDF15
PHO-PNOC-PNOC019OPEN TO ACCRUAL
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG).
PHO-PNOC-PNOC021OPEN TO ACCRUAL
A Phase I Trial Evaluating the Combination of Trametinib and Everolimus in Pediatric and Young Adult Patients with Recurrent Low Grade Gliomas
PHO-SHIH-NWC-HEADSTART4OPEN TO ACCRUAL
NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS: CLINICAL AND MOLECULAR RISK-TAILORED INTENSIVE AND COMPRESSED INDUCTION CHEMOTHERAPY FOLLOWED BY CONSOLIDATION WITH EITHER SINGLE CYCLE (LOW RISK PATIENTS) OR RANDOMIZATION (HIGH RISK PATIENTS) TO either SINGLE-CYCLE or TO THREE TANDEM CYCLES OF MARROW-ABLATIVE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE
PHO-SICKKIDS-BIOBANK-REGISTRYOPEN TO ACCRUAL
The Rare Brain Tumour Consortium Registry and Biobank
  • Clinical Trials
    • About Clinical Trials
    • Should I Participate?
    • Find a Trial
      • by Cancer Type
      • by Doctor
      • by Institution
    • Biobanking: Donating a Part of You to Help Find a Cure.
    • Scientific Review Committee Resources
  • Research Programs
  • DHART SPORE
  • Member Directory
  • Become a Member
  • Shared Facilities
  • Research Resources
  • Funding Opportunities
  • Refer a Patient
NCI-CC A Cancer Center Designated by the National Cancer Institute Big 10 Cancer Research Consortium
Give Now
Fundraising Disclosures: http://go.iu.edu/89n

Block IU Copyright ©  The Trustees of Indiana University, Copyright Complaints, Privacy Notice

Indiana University Melvin and Bren Simon Comprehensive Cancer Center | 535 Barnhill Drive | Indianapolis, IN 46202
Patient Care: (888) 600-4822 | Administrative Office: (317) 278-0070

For accessibility or website issues, contact the webmaster.